Irritable Bowel Syndrome
Conditions
Interventions
intervention group:Chinese medicine particles intestinal Jiling
control group:Placebo
Sponsors
Second Affiliated Hospital of Guangzhou University of TCM
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Western medicine and diagnostic criteria for IBS with diarrhea-predominant type belong to and comply with TCM liver spleen Permit may be included in test cases in line; (2) Informed consent; (3) male or female patient between 18 to 65 years old.
Exclusion criteria
Exclusion criteria: (1) aged under 18 or over 65 years; (2) pregnancy, nursing mothers, or planning a pregnancy; (3) intestinal organic disease, such as inflammatory bowel disease, intestinal tuberculosis, colon polyps; (4) severe cardiovascular system, liver, kidney, hematopoietic system diseases and tumors of patients; (5) Gastrointestinal surgery record reports; (6) severe primary disease and mental illness; (7) There are drug and food allergies or allergies during the test; (8) Not signed informed consent; (9) It does not meet the inclusion criteria, according to the specified medication, can not determine the efficacy or incomplete information and other factors determine the efficacy or safety of persons; (10) researchers believe that clinical trials are not suitable for this.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IBS symptom severity improvement;Significantly reduced rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Action to improve the quality of life of patients;IPatients with bowel symptoms situations (Diary cards);Before and after treatment Hamilton Depression Scale; | — |
Countries
China
Contacts
Public ContactHuang Shaogang
Outcome results
None listed